Core Viewpoint - On February 11, a block trade of 400,000 shares of Aidi Te was executed at a price of 49.66 yuan, representing a discount of 10% compared to the market closing price of 55.18 yuan, with a total transaction value of 19.864 million yuan, accounting for 7.34% of the total trading volume that day [1]. Group 1: Transaction Details - The block trade involved a total of 400,000 shares, with a transaction value of 19.864 million yuan [1]. - The transaction price was set at 49.66 yuan per share, which is 10% lower than the market closing price of 55.18 yuan [1]. - The total trading volume for the day was significantly impacted, with the block trade accounting for 7.34% of the total trading volume [1]. Group 2: Breakdown of Transactions - Multiple transactions were recorded on February 11, with various volumes and values, all at the same price of 49.66 yuan per share [2]. - The largest single transaction recorded was for 100,000 shares, amounting to 4.966 million yuan [2]. - Other transactions included volumes of 57,000 shares (2.8306 million yuan), 48,000 shares (2.3837 million yuan), and 47,000 shares (2.3340 million yuan), all executed at the same price [2].

Core Viewpoint - The company is making significant progress in its 3D printing business, which is expected to become a new core performance driver with notable advantages [1] Group 1: 3D Printing Business Development - The company's 3D printing business is advancing well and is anticipated to be a new core performance engine [1] - The EZprint-P1 printer offers high-speed printing capabilities, completing a half-arch bridge in just 20 minutes, significantly enhancing industry production efficiency [1] - The printing materials used have a solid content of 53% and have received FDA certification, with domestic and EU certifications expected to be finalized soon [1] Group 2: Market Potential and Applications - The company believes the dental 3D printing market has vast development and growth potential [1] - The maturity of 3D printing products and technologies is continuously improving, with applications expanding into various fields such as implants and orthodontics [1] - Relevant clinical solutions have completed market validation, supporting the company's strategic direction [1] Group 3: Competitive Advantage - The company leverages a full-chain layout advantage in materials, equipment, and solutions to deepen its focus on the 3D printing business [1]

证券代码：301580 证券简称：爱迪特 公告编号：2026-002 爱迪特（秦皇岛）科技股份有限公司 关于公司向银行申请综合授信额度的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 三、备查文件 爱迪特（秦皇岛）科技股份有限公司（以下简称"公司"）于 2026 年 2 月 10 日召开了第四届董事会第三次会议，会议审议通过《关于公司向银行申请 综合授信额度的议案》，同意公司及子公司向银行申请总额不超过人民币 9 亿 元（含本数）的综合授信额度，现将议案有关情况公告如下： 1.《爱迪特（秦皇岛）科技股份有限公司第四届董事会第三次会议决议》 特此公告。 一、基本情况 爱迪特（秦皇岛）科技股份有限公司董事会 2026 年 2 月 10 日 为满足公司 2026 年度日常生产经营和业务发展的资金需求，公司及子公司 拟向银行申请合计不超过人民币 9 亿元（含本数）的综合授信额度。授信业务 种类包括但不限于非流动资金贷款、流动资金贷款、信用证、银行票据、外汇 衍生品业务等，上述授信额度仅为公司拟申请的授信额度，具体授信金额需根 据公司实际资金需求，以与银行签署的相 ...

证券代码：301580 证券简称：爱迪特 公告编号：2026-003 爱迪特（秦皇岛）科技股份有限公司 第四届董事会第三次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 爱迪特（秦皇岛）科技股份有限公司（以下简称"公司"）第四届董事会 第三次会议于 2026 年 2 月 10 日在秦皇岛市经济技术开发区都山路 9 号公司会 议室以现场与通讯方式相结合的方式召开。会议通知于 2026 年 2 月 4 日以电子 邮件的方式向全体董事和相关与会人员发出。会议由李洪文先生召集并主持。 会议应出席董事 9 人，实际出席董事 9 人，董事李洪文先生、李斌先生、汪剑 飞先生、王雪松女士、Zhang Yu 先生、傅穹先生、贾国军先生、冯海兰女士以 通讯方式出席会议。公司高级管理人员列席会议。会议召集及召开程序符合 《公司法》等法律法规、规范性文件和《公司章程》的有关规定。 二、董事会会议审议情况 （一）审议通过《关于公司向银行申请综合授信额度的议案》 经审议，为满足公司 2026 年度日常生产经营和业务发展的资金需求，董事 会同意公司及子 ...

Core Viewpoint - The company anticipates that its overall revenue growth pace in 2025 will be consistent with the first three quarters, with profit growth outpacing revenue growth [1] Group 1: Revenue and Profit Growth - The company is experiencing good growth in profitability, with profit growth rate exceeding revenue growth rate [1] - The proportion of overseas business revenue has increased compared to the previous year, becoming a significant support for revenue growth and diversifying the revenue structure [1] Group 2: Global Market Expansion - The company is continuously advancing its global market layout, which helps to mitigate operational risks [1] Group 3: Product Structure Optimization - The company has made positive progress in optimizing its product structure, leading to steady improvement in overall operational quality [1] Group 4: Core Business Focus - In 2025, the company will continue to focus on core materials such as dental zirconia blocks as its business foundation [1] Group 5: Digital Equipment Development - The dental digital equipment business has shown significant development, with multiple devices receiving high market recognition, establishing competitive barriers in product strength, channel reuse, and supply chain [1] - The company plans to increase investment and development in its equipment business [1] Group 6: New Business Breakthroughs - The new business segments have achieved multiple breakthroughs, with rapid advancement in digital full-arch denture business, laying the foundation for large-scale promotion [1] - The implant and 3D printing businesses have also made breakthroughs in both product and market aspects [1] Group 7: Future Reporting - Specific operational data for the fourth quarter and the entire year will be disclosed in the company's upcoming annual report [1]

Core Viewpoint - The company, Aidi Te (301580), is optimistic about its 3D printing business, which is expected to become a new core performance driver with significant advantages [1] Group 1: 3D Printing Business Development - The 3D printing business is progressing well and is anticipated to be a new core performance engine for the company [1] - The EZprint-P1 printer has a high-speed printing advantage, capable of completing a half-arch bridge print in just 20 minutes, significantly enhancing production efficiency in the industry [1] - The supporting printing material has a solid content of 53% and has received FDA certification, with domestic and EU certifications expected to be finalized soon [1] Group 2: Market Potential and Applications - The company believes the oral 3D printing market has vast development and growth potential [1] - The maturity of 3D printing products and technologies is continuously improving, with applications expanding into various fields such as implants and orthodontics [1] - Relevant clinical solutions have completed market validation, supporting the company's strategic direction [1] Group 3: Competitive Advantage - The company leverages its full-chain layout advantages in materials, equipment, and solutions to continue deepening its focus on the 3D printing business [1]

Group 1: 2025 Business Performance - The overall revenue growth in 2025 was consistent with the previous three quarters, with profit growth outpacing revenue growth [2] - The overseas business revenue increased compared to the previous year, becoming a significant support for revenue growth and diversifying the income structure [2] - The company made positive progress in optimizing product structure, leading to steady improvement in overall operational quality [2] Group 2: 2026 Business Outlook - In 2026, the company will focus on both domestic and international markets, enhancing dental processing factories and oral medical service institutions [3] - The company aims to leverage favorable national policies and improve downstream customer competitiveness through new solutions like digital implants and aesthetic restorations [3] - There is confidence in achieving steady growth in performance due to the team's continuous efforts [3] Group 3: 3D Printing Business Progress - The 3D printing business is progressing well and is expected to become a core performance driver, with the EZprint-P1 printer capable of completing half-arch prints in 20 minutes [4] - The printing materials have a solid content of 53% and have received FDA certification, with domestic and EU certifications forthcoming [4] - The company sees significant growth potential in the dental 3D printing market, with applications expanding into various fields such as implants and orthodontics [4] Group 4: Impact of Rare Earth Export Policies - Yttrium oxide, a crucial raw material for the company's upstream suppliers, is affected by stricter rare earth export control policies since 2025 [5] - The market price of yttrium oxide has been rising due to these export restrictions, which may lead to cost pressures in the overseas supply chain if policies persist [5]

Group 1 - The core viewpoint of the article indicates that the company, Aidi Te (301580.SZ), expects its overall revenue growth pace for 2025 to be consistent with the first three quarters, and it anticipates good growth in profitability [2] - The company has scheduled the disclosure date for its 2025 annual report for April 29, 2026, and encourages stakeholders to pay attention to the subsequent annual report for details on its 2025 performance [2]

Core Viewpoint - The company believes that its 3D printing business will become a core performance driver, showcasing significant advantages in the market [1] Group 1: 3D Printing Business Development - The company's 3D printing business is progressing well and is expected to be a new engine for core performance [1] - The EZprint-P1 printer has a high-speed printing advantage, capable of completing a half-arch bridge print in 20 minutes, significantly enhancing production efficiency in the industry [1] - The printing materials used have a solid content of 53% and have received FDA certification, with domestic and EU certifications expected to be finalized soon [1] Group 2: Market Potential and Applications - The company assesses that the dental 3D printing market has vast development and growth potential [1] - The maturity of 3D printing products and technologies is continuously improving, with applications expanding into fields such as implants and orthodontics [1] - Relevant clinical solutions have completed market validation, supporting the company's strategic direction [1] Group 3: Competitive Advantage - The company leverages its full-chain layout advantages in materials, equipment, and solutions to deepen its focus on the 3D printing business [1]

Core Viewpoint - The company, Aidi Te (301580.SZ), is optimistic about its 3D printing business, which is expected to become a new core performance driver with significant advantages [1] Group 1: 3D Printing Business Development - The company's 3D printing business is progressing well and is anticipated to be a new core performance engine [1] - The EZprint-P1 printer has a high-speed printing advantage, capable of completing a half-arch bridge print in 20 minutes, significantly enhancing production efficiency in the industry [1] - The printing materials used have a solid content of 53% and have received FDA certification, with domestic and EU certifications expected to be finalized soon [1] Group 2: Market Potential and Applications - The company believes the dental 3D printing market has vast development and growth potential [1] - The maturity of 3D printing products and technologies is continuously improving, with applications expanding into various fields such as implants and orthodontics [1] - Relevant clinical solutions have completed market validation, supporting the company's strategic direction [1] Group 3: Competitive Advantage - The company leverages its full-chain layout advantages in materials, equipment, and solutions to deepen its focus on the 3D printing business [1]